Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
3/14/2025 | $45.00 | Buy | Truist |
2/11/2025 | $51.00 | Buy | Jefferies |
11/22/2024 | $40.00 | Outperform → Strong Buy | Raymond James |
7/2/2024 | $27.00 | Buy | BofA Securities |
7/2/2024 | $24.00 | Overweight | Barclays |
7/2/2024 | $27.00 | Buy | Deutsche Bank |
7/2/2024 | $32.00 | Buy | Goldman |
7/2/2024 | $24.00 | Overweight | JP Morgan |
LEHI, Utah and LOUISVILLE, Ky., April 7, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the first quarter ended March 31, 2025, after market close on Wednesday, April 30, 2025. The company will discuss its financial results on a conference call at 4:30 p.m. Eastern Time that same day. A live audio webcast of the conference call will be available on Waystar's investor relations website at https://investors.waystar.com/news-events/events. The webcast will be arc
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U
92% of leaders rank AI and advanced automation as a key focus for overcoming industry challenges Patient Access and Claim Management emerge as the top RCM functions prioritized for automation investment LEHI, Utah and LOUISVILLE, Ky., March 4, 2025 /PRNewswire/ -- Waystar (NASDAQ:WAY), a provider of leading healthcare payment software, today announced the results of a comprehensive Qualtrics market survey identifying the top revenue cycle management (RCM) trends of 2025. The study surveyed 600 healthcare RCM, finance, and technology leaders from provider organizations of all types and sizes. The findings show that decision-makers are actively prioritizing AI and advanced automation to addres
144 - Waystar Holding Corp. (0001990354) (Subject)
SCHEDULE 13G/A - Waystar Holding Corp. (0001990354) (Subject)
424B7 - Waystar Holding Corp. (0001990354) (Filer)
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
4 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
Truist initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $45.00
Jefferies initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $51.00
Raymond James upgraded Waystar Holding Corp. from Outperform to Strong Buy and set a new price target of $40.00
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U
LEHI, Utah and LOUISVILLE, Ky., April 7, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the first quarter ended March 31, 2025, after market close on Wednesday, April 30, 2025. The company will discuss its financial results on a conference call at 4:30 p.m. Eastern Time that same day. A live audio webcast of the conference call will be available on Waystar's investor relations website at https://investors.waystar.com/news-events/events. The webcast will be arc
Fiscal year 2024 revenue of $944M, up 19% YoY Q4 revenue growth of 18% year-over-year Q4 net income of $19.1 million and non-GAAP net income of $52.1 million Fiscal year 2024 net loss $19.1 million, 62.7% improvement YoY Fiscal year 2024 adjusted EBITDA of $383M, up 15% YoY Q4 net income margin of 8%; adjusted EBITDA margin of 41% LEHI, Utah and LOUISVILLE, Ky., Feb. 18, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the fourth quarter and full year ended December 31, 2024. "We are please
LEHI, Utah and LOUISVILLE, Ky., Jan. 28, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the fourth quarter and fiscal year ended December 31, 2024, before market open on Tuesday, February 18, 2025. The company will discuss its financial results on a conference call at 8:30 a.m. Eastern Time that same day. A live audio webcast of the conference call will be available on Waystar's investor relations website at https://investors.waystar.com/news-events/events. Th